Wendy’s rejects takeover proposal from Nelson Peltz’s Trian Fund

Wendy’s has officially rejected a $1.4 billion takeover proposal from a group of investors led by Nelson Peltz’s Trian Fund Management, a move that signals a stance against activist pressure. The investor group, which also included BlueFive Capital, Sixth Street Partners, and Flynn Group, offered $7.35 per share in cash on October 28 to take the struggling burger chain private.

Board Rejects Undervalued Proposal

On Thursday, Wendy’s announced its rejection of the proposal. The company’s board formed a special committee of independent directors in February to evaluate the bid. The committee concluded that the offer substantially undervalues Wendy’s and fails to account for the potential gains from its ongoing turnaround strategy. Art Winkleblack, Wendy’s board chair and a member of the independent committee, stated, Our confidence rests firmly in [CEO] Bob Wright’s proven track record of seasoned industry leadership, including restaurant business turnarounds.

Defensive Measures

To stave off the potential hostile takeover, Wendy’s has adopted a shareholder rights plan, also known as a poison pill, with a one-year duration, effective as of Wednesday. The company noted that the investor group led by Trian had previously rejected an offer for a standstill agreement, which would have paused further share purchases. This rejection contributed to Wendy’s decision to implement the poison pill. Trian declined to comment on Wendy’s decision.

Wendy's WEN Stock Surges on $1.4B Nelson Peltz Buyout Offer!

Peltz's History with Wendy's

This rejection is the latest development in a long-running relationship between Peltz and Wendy’s, which dates back to an activist campaign he led over two decades ago. Peltz has a history of ownership with the company; his firm, Triarc, purchased Wendy’s in a $2.3 billion deal in 2008 before selling it again. In 2024, Wendy’s named Peltz as chairman emeritus after 17 years on its board. Wendy’s also reported its third-quarter results on Thursday, noting that same-store sales have declined for seven consecutive quarters, though its quarterly earnings and revenue exceeded Wall Street’s expectations. The company’s stock has lost approximately 60% of its value over the last three years.